技术与方法 |
|
|
|
|
利用Tn5型转座突变系统筛选高产阿维菌素菌株* |
冯宝琪1,冯娇1,张苗1,刘洋2,曹睿2,尹涵之3,齐凤仙3,李子龙3,**(),尹守亮2,**() |
1 华北理工大学基础医学院 唐山 063210 2 华北理工大学生命科学学院 唐山 063210 3 中国科学院微生物研究所 微生物资源前期开发国家重点实验室 北京 100101 |
|
Screening of High Avermectin-producing Strains via Tn5 Transposon Mediated Mutagenesis |
Bao-qi FENG1,Jiao FENG1,Miao ZHANG1,Yang LIU2,Rui CAO2,Han-zhi YIN3,Feng-xian QI3,Zi-long LI3,**(),Shou-liang YIN2,**() |
1 School of Basic Medicine Sciences, North China University of Science and Technology, Tangshan 063210, China 2 School of Life Sciences, North China University of Science and Technology, Tangshan 063210, China 3 State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China |
引用本文:
冯宝琪,冯娇,张苗,刘洋,曹睿,尹涵之,齐凤仙,李子龙,尹守亮. 利用Tn5型转座突变系统筛选高产阿维菌素菌株*[J]. 中国生物工程杂志, 2021, 41(7): 32-41.
Bao-qi FENG,Jiao FENG,Miao ZHANG,Yang LIU,Rui CAO,Han-zhi YIN,Feng-xian QI,Zi-long LI,Shou-liang YIN. Screening of High Avermectin-producing Strains via Tn5 Transposon Mediated Mutagenesis. China Biotechnology, 2021, 41(7): 32-41.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.2102033
或
https://manu60.magtech.com.cn/biotech/CN/Y2021/V41/I7/32
|
[1] |
陈金松, 刘梅, 张立新. 从阿维菌素获得诺贝尔奖到中国创造. 微生物学报, 2016, 56(3):543-558.
|
|
Chen J S, Liu M, Zhang L X. Avermectin, from winning the Nobel Prize to “innovation in China”. Acta Microbiologica Sinica, 2016, 56(3):543-558.
|
[2] |
Ōmura S. A splendid gift from the earth: the origins and impact of the avermectins (Nobel lecture). Angewandte Chemie (International Ed in English), 2016, 55(35):10190-10209.
doi: 10.1002/anie.201602164
|
[3] |
Thuan N H, Pandey R P, Sohng J K. Recent advances in biochemistry and biotechnological synthesis of avermectins and their derivatives. Applied Microbiology and Biotechnology, 2014, 98(18):7747-7759.
doi: 10.1007/s00253-014-5926-x
|
[4] |
Kaur H, Shekhar N, Sharma S, et al. Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes. Pharmacological Reports, 2021, 73(3):736-749.
doi: 10.1007/s43440-020-00195-y
|
[5] |
Mittal N, Mittal R. Inhaled route and anti-inflammatory action of ivermectin: Do they hold promise in fighting against COVID-19. Medical Hypotheses, 2021, 146:110364.
doi: 10.1016/j.mehy.2020.110364
|
[6] |
Chaccour C, Casellas A, Blanco-Di Matteo A, et al. The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: a pilot, double-blind, placebo-controlled, randomized clinical trial. EClinicalMedicine, 2021, 32:100720.
doi: 10.1016/j.eclinm.2020.100720
|
[7] |
Rizzo E. Ivermectin, antiviral properties and COVID-19: a possible new mechanism of action. Naunyn-Schmiedeberg’s Archives of Pharmacology, 2020, 393(7):1153-1156.
doi: 10.1007/s00210-020-01902-5
|
[8] |
年洪娟, 陈丽梅, 李昆志. Tn5转座突变技术在革兰氏阴性细菌分子遗传研究中的应用. 中国生物工程杂志, 2009, 29(12):114-118.
|
|
Nian H J, Chen L M, Li K Z. Application of Tn5 transposon mutagenesis technology in molecular and genetic researches of gram-negative bacteria. China Biotechnology, 2009, 29(12):114-118.
|
[9] |
Weaden J, Dyson P. Transposon mutagenesis with IS6100 in the avermectin-producer Streptomyces avermitilis. Microbiology, 1998, 144(Pt 7):1963-1970.
doi: 10.1099/00221287-144-7-1963
|
[10] |
Volff J N, Altenbuchner J. High frequency transposition of the Tn5 derivative Tn5493 in Streptomyces lividans. Gene, 1997, 194(1):81-86.
pmid: 9266676
|
[11] |
Widenbrant E M, Kao C M. Introduction of the foreign transposon Tn4560 in Streptomyces coelicolor leads to genetic instability near the native insertion sequence IS1649. Journal of Bacteriology, 2007, 189(24):9108-9116.
pmid: 17951387
|
[12] |
Baltz R H, McHenney M A, Cantwell C A, et al. Applications of transposition mutagenesis in antibiotic producing Streptomycetes. Antonie Van Leeuwenhoek, 1997, 71(1-2):179-187.
pmid: 9049029
|
[13] |
Solenberg P J, Baltz R H. Transposition of Tn5096 and other IS493 derivatives in Streptomyces griseofuscus. Journal of Bacteriology, 1991, 173(3):1096-1104.
pmid: 1846854
|
[14] |
Reznikoff W S. Tn5 as a model for understanding DNA transposition. Molecular Microbiology, 2003, 47(5):1199-1206.
pmid: 12603728
|
[15] |
Petzke L, Luzhetskyy A. In vivo Tn5-based transposon mutagenesis of Streptomycetes. Applied Microbiology and Biotechnology, 2009, 83(5):979-986.
doi: 10.1007/s00253-009-2047-z
pmid: 19479250
|
[16] |
Gao H, Liu M, Liu J T, et al. Medium optimization for the production of avermectin B1a by Streptomyces avermitilis 14-12A using response surface methodology. Bioresource Technology, 2009, 100(17):4012-4016.
doi: 10.1016/j.biortech.2009.03.013
|
[17] |
Kieser T, Bibb M J, Buttner M J, et al. Practical Streptomyces Genetics. 2nd ed. Norwich, UK: The John Innes Foundation, 2000: 249-250.
|
[18] |
Yanisch-Perron C, Vieira J, Messing J. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mpl8 and pUC19 vectors. Gene, 1985, 33(1):103-119.
pmid: 2985470
|
[19] |
Yin S L, Wang W S, Wang X F, et al. Identification of a cluster-situated activator of oxytetracycline biosynthesis and manipulation of its expression for improved oxytetracycline production in Streptomyces rimosus. Microbial Cell Factories, 2015, 14:46.
doi: 10.1186/s12934-015-0231-7
|
[20] |
Yang T J, Yang K Q, Chen Y H, et al. Characterization of a Bi-directional promoter OtrRp involved in oxytetracycline biosynthesis. Current Microbiology, 2019, 76(11):1264-1269.
doi: 10.1007/s00284-019-01753-1
|
[21] |
Wang W S, Li X, Wang J, et al. An engineered strong promoter for Streptomycetes. Applied and Environmental Microbiology, 2013, 79(14):4484-4492.
doi: 10.1128/AEM.00985-13
|
[22] |
Siegl T, Tokovenko B, Myronovskyi M, et al. Design, construction and characterisation of a synthetic promoter library for fine-tuned gene expression in actinomycetes. Metabolic Engineering, 2013, 19:98-106.
doi: 10.1016/j.ymben.2013.07.006
|
[23] |
周华艳, 周长林, 窦洁, 等. 阿维链霉菌QL0827接合转移体系的建立. 生物技术通讯, 2016, 27(2):188-191.
|
|
Zhou H Y, Zhou C L, Dou J, et al. Construction of conjugal transfer system of Streptomyces avermitilis QL0827. Letters in Biotechnology, 2016, 27(2):188-191.
|
[24] |
Wang X K, Jin J L. Crucial factor for increasing the conjugation frequency in Streptomyces netropsis SD-07 and other strains. FEMS Microbiology Letters, 2014, 357(1):99-103.
doi: 10.1111/fml.2014.357.issue-1
|
[25] |
孟令卓, 王勇, 储炬. 阿维链霉菌转化系统的优化及其不同PKS敲除菌株的构建. 中国医药工业杂志, 2018, 49(8):1112-1120.
|
|
Meng L Z, Wang Y, Chu J. Construction of 7 PKS-deleted mutants for Streptomyces avermitilis and improvement of conjugal transformation system. Chinese Journal of Pharmaceuticals, 2018, 49(8):1112-1120.
|
[26] |
杜茜, 张红丹, 张正坤, 等. 链霉菌769接合转移体系的建立. 吉林农业科学, 2012, 37(2):30-33.
|
|
Du Q, Zhang H D, Zhang Z K, et al. Construction of conjugal transfer system of Streptomyces ahygroscopicus gongzhulingensis. Journal of Jilin Agricultural Sciences, 2012, 37(2):30-33.
|
[27] |
孟令卓, 王勇, 储炬. 阿维链霉菌中一个双组分调控系统SAV931/932功能初探. 华东理工大学学报(自然科学版), 2015, 41(4):443-448.
|
|
Meng L Z, Wang Y, Chu J. Characterization of two-component system SAV931/932 for the biosynthesis of avermectin in Streptomyces avermitilis. Journal of East China University of Science and Technology (Natural Science Edition), 2015, 41(4):443-448.
|
[28] |
文莹, 张立新. 阿维菌素的中国“智”造. 遗传, 2018, 40(10):888-899.
|
|
Wen Y, Zhang L X. Avermectins, intelligently made in China. Hereditas, 2018, 40(10):888-899.
|
[29] |
Chen J S, Liu M, Liu X T, et al. Interrogation of Streptomyces avermitilis for efficient production of avermectins. Synthetic and Systems Biotechnology, 2016, 1(1):7-16.
doi: 10.1016/j.synbio.2016.03.002
|
[30] |
Ikeda H, Ishikawa J, Hanamoto A, et al. Complete genome sequence and comparative analysis of the industrial microorganism Streptomyces avermitilis. Nature Biotechnology, 2003, 21(5):526-531.
doi: 10.1038/nbt820
|
[31] |
曹晓梅. 阿维菌素高产菌株的定向选育. 无锡: 江南大学, 2018.
|
|
Cao X M. Directive breeding of avermectin-high-producing strains. Wuxi, China: Jiangnan University, 2018.
|
[32] |
宋渊, 曹贵明, 陈芝, 等. 阿维菌素高产菌株的选育及阿维菌素B1的鉴定. 生物工程学报, 2000, 16(1):31-35.
pmid: 10883272
|
|
Song Y, Cao G M, Chen Z, et al. Selection of high avermectins producing strain and identification of avermectin B1. Chinese Journal of Biotechnology, 2000, 16(1):31-35.
pmid: 10883272
|
[33] |
薄永恒. 阿维链霉菌高产菌株诱变选育及其基因与蛋白差异效果研究. 兰州: 甘肃农业大学, 2012.
|
|
Bo Y H. Research on the mutation breeding of high avermectin producing strains and the mutagenic effect about genes and proteins of Streptomyces avermitilis. Lanzhou: Gansu Agricultural University, 2012.
|
[34] |
Metcalf W W, Jiang W H, Wanner B L. Use of the rep technique for allele replacement to construct new Escherichia coli hosts for maintenance of R6Kλ origin plasmids at different copy numbers. Gene, 1994, 138(1-2):1-7.
pmid: 8125283
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|